A New AI Drug-Discovery Startup Tests Whether Research Talent Can Become A Biotech Business

Reports that OpenAI researcher Miles Wang is planning an AI drug-discovery company show how the competition for frontier talent is spilling into a biotech market where model capability must still survive laboratory reality.